Influenza evolution and H3N2 vaccine effectiveness, with application to the 2014/2015 season
- PMID: 27313229
- PMCID: PMC4955871
- DOI: 10.1093/protein/gzw017
Influenza evolution and H3N2 vaccine effectiveness, with application to the 2014/2015 season
Abstract
Influenza A is a serious disease that causes significant morbidity and mortality, and vaccines against the seasonal influenza disease are of variable effectiveness. In this article, we discuss the use of the pepitope method to predict the dominant influenza strain and the expected vaccine effectiveness in the coming flu season. We illustrate how the effectiveness of the 2014/2015 A/Texas/50/2012 [clade 3C.1] vaccine against the A/California/02/2014 [clade 3C.3a] strain that emerged in the population can be estimated via pepitope In addition, we show by a multidimensional scaling analysis of data collected through 2014, the emergence of a new A/New Mexico/11/2014-like cluster [clade 3C.2a] that is immunologically distinct from the A/California/02/2014-like strains.
Keywords: dominant strains; influenza evolution; pepitope; phylogeny; vaccine effectiveness.
© The Author 2016. Published by Oxford University Press.
Figures




Similar articles
-
Genetic and antigenic characterization of influenza A(H3N2) in Cameroon during the 2014-2016 influenza seasons.PLoS One. 2017 Sep 6;12(9):e0184411. doi: 10.1371/journal.pone.0184411. eCollection 2017. PLoS One. 2017. PMID: 28877235 Free PMC article.
-
In-depth phylogenetic analysis of the hemagglutinin gene of influenza A(H3N2) viruses circulating during the 2016-2017 season revealed egg-adaptive mutations of vaccine strains.Expert Rev Vaccines. 2020 Jan;19(1):115-122. doi: 10.1080/14760584.2020.1709827. Epub 2020 Jan 19. Expert Rev Vaccines. 2020. PMID: 31875483
-
Interim estimates of divergence date and vaccine strain match of human influenza A(H3N2) virus from systematic influenza surveillance (2010-2015) in Hangzhou, southeast of China.Int J Infect Dis. 2015 Nov;40:17-24. doi: 10.1016/j.ijid.2015.09.013. Epub 2015 Sep 28. Int J Infect Dis. 2015. PMID: 26417878
-
H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluation.Hum Vaccin Immunother. 2018;14(8):1840-1847. doi: 10.1080/21645515.2018.1462639. Epub 2018 May 14. Hum Vaccin Immunother. 2018. PMID: 29641358 Free PMC article. Review.
-
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses.Vaccine. 2008 Sep 12;26 Suppl 4:D31-4. doi: 10.1016/j.vaccine.2008.07.078. Vaccine. 2008. PMID: 19230156 Review.
Cited by
-
Prediction of Antigenic Distance in Influenza A Using Attribute Network Embedding.Viruses. 2023 Jun 29;15(7):1478. doi: 10.3390/v15071478. Viruses. 2023. PMID: 37515165 Free PMC article.
-
Next-Generation Computationally Designed Influenza Hemagglutinin Vaccines Protect against H5Nx Virus Infections.Pathogens. 2021 Oct 20;10(11):1352. doi: 10.3390/pathogens10111352. Pathogens. 2021. PMID: 34832509 Free PMC article.
-
Assessing antigenic drift and phylogeny of influenza A (H1N1) pdm09 virus in Kenya using HA1 sub-unit of the hemagglutinin gene.PLoS One. 2020 Feb 11;15(2):e0228029. doi: 10.1371/journal.pone.0228029. eCollection 2020. PLoS One. 2020. PMID: 32045419 Free PMC article.
-
Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.J Virol. 2019 Jan 17;93(3):e00946-18. doi: 10.1128/JVI.00946-18. Print 2019 Feb 1. J Virol. 2019. PMID: 30429350 Free PMC article.
-
Imprinting of Repeated Influenza A/H3 Exposures on Antibody Quantity and Antibody Quality: Implications for Seasonal Vaccine Strain Selection and Vaccine Performance.Clin Infect Dis. 2018 Oct 30;67(10):1523-1532. doi: 10.1093/cid/ciy327. Clin Infect Dis. 2018. PMID: 29672713 Free PMC article.
References
-
- Ansaldi F., Zancolli M., Durando P., Montomoli E., Sticchi L., Del Giudice G., Icardi G. (2010) Vaccine, 28, 4123–4129. - PubMed
-
- Castilla J., Martinez-Baz I., Martinez-Artola V. (2013) Euro Surveill., 18, pii: 20388.
-
- Castilla J., Martınez-Baz I., Navascués A. et al. (2014) Euro Surveill., 19, 20700.
-
- Daly J.M., Elton D. (2013) Vaccine, 31, 6043–6045. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical